Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients
- 1 September 2013
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 81 (3) , 455-461
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Leukoencephalopathy after whole‐brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancerCancer, 2012
- Brain metastases from non-small-cell lung cancer: is there room for improvement?Expert Review of Anticancer Therapy, 2012
- Evidence-Based Guidelines for the Management of Brain MetastasesNeurosurgery Clinics of North America, 2011
- Novel insights into the management of brain metastasesCurrent Opinion in Neurology, 2010
- Factors associated with the development of brain metastasesCancer, 2010
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinomaLung Cancer, 2004
- Brain MetastasesCNS Drugs, 2002
- Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy.Journal of Clinical Oncology, 1994
- Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis.Journal of Clinical Oncology, 1988